Skip to main content
SERA PROGNOSTICS, INC. logo

SERA PROGNOSTICS, INC. — Investor Relations & Filings

Ticker · SERA ISIN · US81749D1072 US Manufacturing
Open in API
Filings indexed 561 across all filing types
Latest filing 2021-07-21 Director's Dealing
Country US United States of America
Listing US SERA

About SERA PROGNOSTICS, INC.

https://www.sera.com/

Sera Prognostics, Inc., also known as 'The Pregnancy Company®', is a health diagnostics company focused on improving maternal and infant health through precision pregnancy care. The company's flagship product is the PreTRM® Test, a first-of-its-kind biomarker blood test designed to predict the individual risk of spontaneous preterm birth in asymptomatic women with singleton pregnancies. The test is administered via a single blood draw during the 18th to 20th week of gestation, providing pivotal information to physicians for proactive management. Sera Prognostics also offers the LikeMine™ platform, which uses data from millions of pregnancies to offer comparative insights. The company aims to deliver high-value diagnostics to providers, mothers, payers, and employers to improve health outcomes and reduce healthcare costs associated with premature birth.

Recent filings

Filing Released Lang Actions
OWNERSHIP DOCUMENT
Director's Dealing
2021-07-21 English
FORM 8-K
Regulatory Filings Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content includes amendments to the articles of incorporation and bylaws, completion of an initial public offering (IPO), and references to exhibits containing the amended certificate and bylaws. There are no financial statements or detailed financial data presented, nor is this an annual or quarterly report. The document is not a proxy statement, earnings release, or management discussion. It is a regulatory filing announcing corporate governance changes and a capital event (IPO completion). Given the nature of Form 8-K filings and the content, the best classification is Regulatory Filings (RNS), which is the fallback for miscellaneous SEC filings that do not fit other categories. The document length is 4309 characters, which is relatively short and consistent with an 8-K announcement rather than a full report.
2021-07-20 English
424B4
Capital/Financing Update Classification · 95% confidence The document is a detailed prospectus for an initial public offering (IPO) of Class A common stock by Sera Prognostics, Inc. It includes information about the offering size, price, underwriting, risk factors, business overview, management, financial statements, and other disclosures typical of a registration statement filed with the SEC. The form type mentioned is 424B4, which is a prospectus filed pursuant to Rule 424(b)(4) under the Securities Act, used for securities offerings. This document is not a financial report like an annual or quarterly report, nor is it a management discussion, earnings release, or any other category related to ongoing company operations or governance. Instead, it is a capital markets document related to the company's fundraising and issuance of new shares to the public. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is a full prospectus, not a brief announcement or regulatory filing. Confidence is high given the clear identification of the document type and content.
2021-07-16 English
Regulatory Filings 2021
Regulatory Filings
2021-07-15 English
Regulatory Filings 2021
Regulatory Filings
2021-07-15 English
OWNERSHIP DOCUMENT
Director's Dealing
2021-07-15 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.